Trials / Recruiting
RecruitingNCT07254013
Left Bundle Branch Area Pacing (LBBAP) Monitoring Assistant: Evaluation of Portable ECG Solution
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 55 (estimated)
- Sponsor
- MicroPort CRM · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the capability to monitor LBB success criteria with the use of a Smart ECG system (ECG monitor, 12 leads ECG cable, ECG viewer software ) during a cardiac device implantation involving the placement of a pacing lead in interventricular septum area
Detailed description
The clinical investigation aims to support physicians with a portable and easy to use solution to display ECG and to provide automatic calculation of key ECG indicators (Left Ventricular Activation time (LVAT) and V6-V1 interval) for LBB implantation procedure. This allows physicians to concentrate on lead placement with the benefice from immediate ECG measurements thanks to the automatic software. The Smart ECG system is class IIA device and it is composed of: 1. CE-marked Smart ECG, Class IIa medical device (rule 10 Annex VIII of MDR) 2. ECG viewer Software (HookUp SmarV2) (providing 12 lead ECG display + automatic interval measurements + shadow plot for QRS visualization) Class IIa medical device (rule 11 Annex VIII of MDR). 3. CE -marked 12 leads ECG cables radiotransparent and defibrillation proof (Class I device) 4. Commercial PC used in combination with the devices under evaluation The study is a pre-market, non-pivotal study: HookUp Smart V2 software is a non-implantable Class IIA device, with no interaction with the human body and the demonstration of conformity with general safety and performance requirements is based on the results of non-clinical testing methods alone (as article 61(10) from MDR.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LBBAP implant | Use of Smart ECG system during the LBB implant |
Timeline
- Start date
- 2025-11-14
- Primary completion
- 2026-02-28
- Completion
- 2026-03-31
- First posted
- 2025-11-28
- Last updated
- 2025-12-05
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT07254013. Inclusion in this directory is not an endorsement.